Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of α-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility
Authors:
- Jyothish B PillaiJPJyothish B Pillai
- Madhu GuptaMGMadhu Gupta
- Mahesh P. GuptaMGMahesh P. Gupta
Open Access
- 1 March 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (3) , H1477-H1490
Abstract
Histone deacetylases (HDACs) are a family of enzymes that catalyze the removal of acetyl groups from core histones, resulting in change of chromatin structure and gene transcription activity. In the heart, HDACs are targets of hypertrophic signaling, and their nonspecific inhibition by trichostatin A (TSA) attenuates hypertrophy of cultured cardiac myocytes. In this study, we examined the effect of TSA on two major determinants of cardiac contractility: α-myosin heavy chain (MHC) expression and microtubular composition and organization. TSA upregulated the expression of α-MHC in cultured cardiac myocytes, as well as in an in vivo model of hypothyroid rats. Studies designed to delineate mechanisms of α-MHC induction by TSA revealed an obligatory role of early growth response factor-1 on activation of the α-MHC promoter. Concurrently, TSA downregulated the expression of α- and β-tubulins and prevented the induction of tubulins by a hypertrophy agonist, ANG II. The ANG II-mediated increased proportion of α- and β-tubulins associated with polymerized microtubules was also markedly reduced after treatment of cells by TSA. Results obtained from immunofluorescent microscopy indicated that TSA had no noticeable effect on the organization of cardiac microtubules in control cells, whereas it prevented the ANG II-induced dense parallel linear arrays of microtubules to a profile similar to that of controls. Together, these results demonstrate that inhibition of HDACs by TSA regulates the cardiac α-MHC and tubulins in a manner predictive of improved cardiac contractile function. These studies improve our understanding of the role of HDACs on cardiac hypertrophy with implications in development of new therapeutic agents for treatment of cardiac abnormalities.Keywords
This publication has 54 references indexed in Scilit:
- Quantitation and Distribution of β-tubulin in Human Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 2002
- Reciprocal Regulation of β1-Adrenergic Receptor Gene Transcription by Sp1 and Early Growth Response Gene 1: Induction of EGR-1 Inhibits the Expression of the β1-Adrenergic Receptor GeneMolecular Pharmacology, 2002
- HDAC4 deacetylase associates with and represses the MEF2 transcription factorThe EMBO Journal, 1999
- Modification of Chromatin Structure by the Thyroid Hormone ReceptorTrends in Endocrinology & Metabolism, 1999
- Serum response factor is essential for mesoderm formation during mouse embryogenesisThe EMBO Journal, 1998
- Role of Microtubules in the Viscoelastic Properties of Isolated Cardiac MuscleJournal of Molecular and Cellular Cardiology, 1998
- Microtubule Stabilization in Pressure Overload Cardiac HypertrophyJournal of Cell Biology, 1997
- α-myosin Heavy Chain Gene Regulation: Delineation and Characterization of the Cardiac Muscle-specific Enhancer and Muscle-specific PromoterJournal of Molecular and Cellular Cardiology, 1996
- Detyrosination of alpha tubulin does not stabilize microtubules in vivo [published erratum appears in J Cell Biol 1990 Sep;111(3):1325-6]Journal of Cell Biology, 1990
- Assembly and turnover of detyrosinated tubulin in vivo.Journal of Cell Biology, 1987